Drug reference

atropine methonitrate

Semisynthetic anticholinergic, Quaternary compound · Antispasmodic

Semisynthetic anticholinergic, Quaternary compoundAntispasmodic

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

—

not curated

Mechanism

Atropine methonitrate is a semisynthetic anticholinergic derivative that blocks muscarinic receptors to provide antispasmodic and antisecretory effects.

Indications

Abdominal colicsHyperacidity

Dosing

Adult: 2.5–10 mg oral, i.m.

Related guidelines

Intra-abdominal infection

WSES · Surgery · 2017

Irritable bowel syndrome

ISG · Gastroenterology · 2023

Extrapulmonary tuberculosis

ICMR · Infectious Diseases · 2022

Other Semisynthetic anticholinergic, Quaternary compound drugs

pipenzolate methyl bromide

0 brands

propantheline

0 brands

Ask House about atropine methonitrate

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team